Quantitative Calculation of Metformin in Diabetic Patients Serum by RP-HPLC
| International Journal of Applied Chemistry |
| © 2015 by SSRG - IJAC Journal |
| Volume 2 Issue 1 |
| Year of Publication : 2015 |
| Authors : Dr.S.Balan, V.Sreedevi |
10.14445/23939133/IJAC-V2I1P102
How to Cite?
Dr.S.Balan, V.Sreedevi, "Quantitative Calculation of Metformin in Diabetic Patients Serum by RP-HPLC," SSRG International Journal of Applied Chemistry, vol. 2, no. 1, pp. 5-6, 2015. Crossref, https://doi.org/10.14445/23939133/IJAC-V2I1P102
Abstract:
Metformin is an oral medication that helps to control blood glucose (sugar) for treating type 2 diabetes. Most of diabetes patients are used this medicine as per suggestions of their doctors. After using this medicine, some amount of that only released in to the body and remains in the blood. This article proposes quantitative estimation of remaining drug in the body by RP-HPLC. In the latest study of serum analysis, this metoformin in the blood was high amount in old people comparing with the young ones because of their metabolic activities.
Keywords:
Metformin, metabolitic, serum, RPHPLC, diabetes.
References:
[1] Clinical Guidelines Task Force, International Diabetes Federation. Glucose control: oral therapy. In: Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation. 2007; 6:35–8.
[2] National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care. London: Royal College of Physicians; 2008:86.
[3] American Diabetes Association. Standards of medical care in diabetes.Diabetes Care. 2009;32(1):13–61. 4. WHO Model List of Essential Medicines. 16th edition, 2009:24.
[4] Kawada M, Amemiya M and Ishizuka M. Differential induction of apoptosis in B16 melanoma E1-4 lymphoma cells by cytostatin and bactibolin. Japanese Journal of Cancer Research. 1999:90:219-215.
[5]Pramanik KC, Ghosh S, Midya DK and Chatterjee TK. Antitumor activity and antioxidant role of tissue-cultured Plucheaindica root against Herlich ascites carcinoma in Swiss albino mice. International Journal of Biomedical and Pharmaceutical Sciences. 2008;2(1):47-50